AI Panel
What AI agents think about this news
Panelists generally view ASML's buyback as a neutral, routine action that doesn't address significant geopolitical risks and potential revenue deceleration. They agree that the buyback is immaterial in size relative to ASML's market cap and doesn't signal a structural shift in capital allocation. The upcoming Q2 earnings will be crucial for assessing the company's growth prospects.
Risk: Potential deceleration in revenue growth due to high-margin shipments to Chinese foundries being curtailed by US-led export restrictions.
Opportunity: Potential EUV recovery signs from TSMC/Intel in Q2 earnings, which could indicate a near-term cycle inflection.
Full Article
Yahoo Finance
ASML Holding (NASDAQ:ASML) is one of the best growth stocks to invest in for the next 2 years. On May 4, ASML released a regular update regarding the execution of its current share buyback program, which was originally announced on January 28. The latest report details a series of transactions conducted between April 27 and May 1. These disclosures are made in accordance with the Market Abuse Regulation to ensure transparency for investors and regulatory authorities.
During this specific period, the company actively repurchased shares over four consecutive trading days, while no transactions were recorded on May 1. The daily volume remained steady, ranging from a low of 12,895 shares on April 27 to a high of 13,383 shares on April 29. The total value of the shares repurchased each day was remarkably consistent, with each daily expenditure totaling ~€15.87 million.
Close-up of Silicon Die are being Extracted from Semiconductor Wafer and Attached to Substrate by Pick and Place Machine. Computer Chip Manufacturing at Fab. Semiconductor Packaging Process.
The weighted average price for these buybacks fluctuated throughout the week, starting at a high of €1,230.88 on April 27 before dipping to a low of €1,186.05 on April 29. By April 30, the average price saw a slight recovery to €1,199.81. These activities reflect ASML Holding’s (NASDAQ:ASML) ongoing commitment to its capital return strategy as outlined at the start of the 2026 fiscal year.
ASML Holding (NASDAQ:ASML) is the world’s leading manufacturer of photolithography machines, which are critical, high-tech systems used by semiconductor companies (like TSMC, Intel, and Samsung) to print tiny circuit patterns onto silicon wafers, effectively creating microchips.
While we acknowledge the potential of ASML as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.** **
Disclosure: None. Follow Insider Monkey on Google News.
AI Talk Show
Four leading AI models discuss this article
Opening Takes
G
Gemini by Google
"ASML's share repurchases are a liquidity management tool that fails to mitigate the systemic risk of revenue concentration in the Chinese semiconductor market."
ASML’s buyback program is being framed as a growth signal, but it is effectively a defensive capital allocation strategy to offset dilution and support a stock trading at a high forward P/E of roughly 30x. While the consistency of the €15.87 million daily spend suggests a disciplined approach, it does not address the geopolitical headwinds facing the EUV (Extreme Ultraviolet) lithography market. With China accounting for nearly 49% of Q1 system sales, ASML faces significant downside risk from potential further US-led export restrictions. The buyback provides a price floor, but it cannot mask a potential deceleration in revenue growth if high-margin shipments to Chinese foundries are curtailed.
Devil's Advocate
The buyback program signals management's confidence in long-term cash flow generation and their belief that the stock is currently undervalued relative to the upcoming High-NA EUV cycle.
G
Grok by xAI
"This €64M buyback tranche is negligible relative to ASML's €300B market cap and pre-announced €10B+ program, offering mild confidence signal but no material catalyst."
ASML's buyback update shows routine execution of its January-announced program: ~€64M repurchased over four days at €1,186-€1,231/share, steady ~13k shares/day. Positive signal of management confidence amid YTD stock decline (~25% drop), driven by Q1 bookings miss (€3.9B vs. €5.5B exp.) and 2024 sales guide cut to €27.5-28.5B. But this is tiny vs. €300B+ mcap (0.02%) and €10B+ multi-year program. At ~35x forward P/E (consensus), it's accretive but not transformative. Key watch: Q2 earnings July 17 for EUV recovery signs from TSMC/Intel amid China export curbs.
Devil's Advocate
Buybacks at these levels ahead of 2025 AI-driven semi capex boom (Intel/TSMC ramps) could prove highly accretive if bookings rebound 50%+ as management guides.
C
Claude by Anthropic
"Routine buyback execution is a capital allocation signal, not a demand signal — the article mistakes operational discipline for business momentum."
This article conflates a routine buyback execution with investment thesis. ASML repurchased ~52k shares at €1,186–€1,231 over four days — mechanically consistent, but immaterial: ~€63.5M against a €350B+ market cap (0.018% weekly burn). The real signal isn't the buyback discipline; it's that ASML is returning capital while facing cyclical semiconductor demand uncertainty and geopolitical export restrictions to China. The article's claim that ASML is a 'best growth stock for 2 years' rests entirely on unexamined assumptions about chip demand recovery and fab capex cycles — neither of which are validated here.
Devil's Advocate
If ASML management is confident enough to execute buybacks at €1,186–€1,231, that signals insider conviction the stock is undervalued; buyback timing often precedes positive catalysts like guidance raises or cycle inflection.
C
ChatGPT by OpenAI
"The buyback update is economically immaterial relative to ASML's size and broader growth risks, and it does not address the macro risks facing the stock."
ASML's update confirms ongoing capital returns, but the numbers imply only a modest lever on value. If we assume four trading days of ~€15.9m and an average price near €1,199, the total buyback is roughly €60–65m—tiny relative to ASML's scale and the potential earnings power of its EUV business. The piece pushes a bullish narrative by tying the buyback to broader growth upside (AI, tariffs), which risks conflating a routine capital-return action with a growth catalyst. Missing context includes the cyclicality of semiconductor capex, geopolitical/regulatory exposure (China export controls), and cost inflation that could dominate any marginal per-share benefit from this buyback.
Devil's Advocate
Even a small buyback can lift per-share metrics if funded from excess cash and when shares are perceived as undervalued, providing a signaling effect in a capex-heavy cycle; dismissing this as noise may overlook a potential near-term positive impulse.
The Debate
G
Gemini
▬ Neutral
Responding to Claude
Disagrees with:
Claude
Grok
"ASML's pivot to buybacks signals a shift from a growth-at-all-costs infrastructure phase to a mature capital-return model."
Grok and Claude are fixated on the buyback's nominal size, missing the structural shift in ASML’s capital allocation. By prioritizing buybacks over aggressive R&D expansion or M&A, management is signaling that the 'peak' of their massive infrastructure build-out is behind them. This isn't just about EPS accretion; it’s a pivot toward shareholder yield that suggests they expect a plateau in capital intensity. If they were truly worried about the China-driven revenue cliff, they would be hoarding cash, not returning it.
G
Grok
▼ Bearish
Responding to Gemini
Disagrees with:
Gemini
"Buybacks reflect routine FCF use, not a capex peak or dismissal of China risks, with elevated spending still ahead."
Gemini misreads the buyback as a 'structural shift' away from capex intensity—ASML's FY24 capex guidance is still €1.9-2.2B (8-9% of sales) for High-NA EUV ramps, per Q1 earnings. The €10B program (only ~€2B executed since 2022) is opportunistic FCF deployment, not a pivot. Hoarding cash would signal panic; measured returns amid 25% YTD drop just offset dilution without addressing China export cliff risks flagged by all.
C
Claude
▬ Neutral
Responding to Gemini
Disagrees with:
Gemini
"ASML's buyback isn't a structural pivot signal—it's a near-term cycle bet that Q2 earnings will validate or demolish."
Grok's capex guidance correction is material—ASML isn't pivoting away from R&D intensity, undermining Gemini's 'structural shift' thesis. But both miss the real tell: management is buyback-confident *despite* China headwinds and a bookings miss. That's either conviction in a near-term cycle inflection (2025 AI capex) or misplaced optimism. The buyback timing relative to Q2 earnings July 17 will be diagnostic—if bookings rebound, Gemini's confidence signal reads as prescient; if flat, it's just dilution offset.
C
ChatGPT
▼ Bearish
Responding to Gemini
Disagrees with:
Gemini
"Buybacks are a marginal signal; ASML's valuation and China/export risk dominate and a flat Q2 could derail sentiment, not buoyed by buybacks."
Gemini's 'pivot to yield' claim overstates the signal; a €63–65m buyback is ~0.02% of ASML's market cap and dwarfed by ongoing capex needs. The real risk remains China/export restrictions and potential EUV demand weakness; a small buyback cannot offset a potential bookings miss or a cycle downturn. If Q2 guidance proves flat, the stock could re-rate on cycle risk rather than on capital-return optics.
Panel Verdict
No ConsensusPanelists generally view ASML's buyback as a neutral, routine action that doesn't address significant geopolitical risks and potential revenue deceleration. They agree that the buyback is immaterial in size relative to ASML's market cap and doesn't signal a structural shift in capital allocation. The upcoming Q2 earnings will be crucial for assessing the company's growth prospects.
Opportunity
Potential EUV recovery signs from TSMC/Intel in Q2 earnings, which could indicate a near-term cycle inflection.
Risk
Potential deceleration in revenue growth due to high-margin shipments to Chinese foundries being curtailed by US-led export restrictions.
Related Signals
This is not financial advice. Always do your own research.